Malezya Parkinson hastalarının çok etnikli bir kohortunda LRRK2 varyant spektrumu ve dernek çalışması

Araştırma özeti

Aşağıdaki metin kaynak makalenin lisansı doğrulanmış orijinal özetidir. cc by

Abstract The variant spectrum of LRRK2 in the multi-ancestry Malaysian population remains largely uncharacterized. In this study, 2,034 Parkinson’s disease (PD) patients and 1,059 controls (Malays, Chinese, Indians and Indigenous) were screened. Seventy-seven heterozygous non-synonymous variants were identified, including four known pathogenic/likely pathogenic variants (p.R1067Q, p.R1325Q, p.R1441C/H) and three risk alleles (p.A419V, p.R1628P, p.G2385R). There were 51 variants of uncertain significance (VUS), including two high-interest VUS (p.A1413T, p.P1446L) and five novel VUS (p.L162F, p.D523N, p.F877S, p.E1566D, p.D1858A). In the Chinese cohort, the p.G2385R variant was significantly associated with increased PD risk by 3.2-fold. After Bonferroni correction, the p.R1628P risk allele and the p.N551K-p.R1398H-p.K1423K protective haplotype associations were not significant. Double heterozygous p.R1628P-p.G2385R patients were observed to have a mean age at diagnosis (AAD) of 54.4 ±12.1 years while non- LRRK2 carriers had a mean AAD of 59.0 ±12.0 years. Domain-based low-frequency and rare variant tests highlighted the WD40 domain, largely driven by the p.G2385R variant, as disease-relevant for the Chinese subgroup. Overall, this study offers the most comprehensive catalog of LRRK2 variation in the Malaysian population to date, providing a valuable resource for future genetic studies of Southeast Asian ancestries, and aiding in the development of relevant LRRK2 -targeted therapies.

İlgili konular